Literature DB >> 17065573

Circulating renin Angiotensin system in childhood chronic renal failure: marked increase of Angiotensin-(1-7) in end-stage renal disease.

Ana C Simões e Silva1, José Silvério S Diniz, Regina M Pereira, Sérgio V Brant Pinheiro, Robson Augusto S Santos.   

Abstract

The aim of the present study was to evaluate plasma renin activity (PRA) and Angiotensin (Ang) levels [Ang I, Ang II and Ang-(1-7)] to examine the circulating Renin-Angiotensin System (RAS) in renal disease among children with different forms and stages of chronic renal failure (CRF). Subjects were divided as follows: 32 normotensive healthy subjects, 23 normotensive CRF subjects, 34 hypertensive CRF subjects and 21 subjects with end-stage renal disease (ESRD). Radioimmunoassays for PRA (ngAngI/mL/h) and angiotensin (pg/mL) measurements were performed on all subjects. PRA, Ang I, Ang II and Ang-(1-7) levels were significantly higher in hypertensive CRF subjects when compared with normotensive CRF and healthy subjects (p < 0.05 for all comparisons). No differences were observed between normotensive CRF and healthy subjects. ESRD subjects exhibited a dramatic increase in Ang-(1-7) (25-fold higher than control values). In hypertensive CRF subjects, treatment with angiotensin-converting enzyme inhibitors (ACEi) increased (1.4-fold) plasma Ang-(1-7) and decreased (2.4-fold) Ang II. In ESRD, the use of ACEi produced a similar (1.5-fold) elevation of Ang-(1-7), but no changes in plasma Ang II. Our data showed different circulating RAS profiles between hypertensive and in normotensive CRF subjects. Marked changes in plasma Ang-(1-7) were associated with the presence of hypertension and progression of kidney dysfunction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17065573     DOI: 10.1203/01.pdr.0000246100.14061.bc

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  25 in total

Review 1.  The renin-angiotensin-aldosterone system in 2011: role in hypertension and chronic kidney disease.

Authors:  Ana Cristina Simões E Silva; Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2011-09-23       Impact factor: 3.714

2.  Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7).

Authors:  Carlos M Ferrario; Sarfaraz Ahmad; Janae Joyner; Jasmina Varagic
Journal:  Adv Pharmacol       Date:  2010

Review 3.  Hypertension and hemodialysis: pathophysiology and outcomes in adult and pediatric populations.

Authors:  Peter N Van Buren; Jula K Inrig
Journal:  Pediatr Nephrol       Date:  2011-02-01       Impact factor: 3.714

4.  Antenatal corticosteroids and the renin-angiotensin-aldosterone system in adolescents born preterm.

Authors:  Andrew M South; Patricia A Nixon; Mark C Chappell; Debra I Diz; Gregory B Russell; Beverly M Snively; Hossam A Shaltout; James C Rose; T Michael O'Shea; Lisa K Washburn
Journal:  Pediatr Res       Date:  2016-09-16       Impact factor: 3.756

Review 5.  Hypertension in Pediatric Dialysis Patients: Etiology, Evaluation, and Management.

Authors:  Raj Munshi; Joseph T Flynn
Journal:  Curr Hypertens Rep       Date:  2018-06-08       Impact factor: 5.369

Review 6.  ACE2 (Angiotensin-Converting Enzyme 2), COVID-19, and ACE Inhibitor and Ang II (Angiotensin II) Receptor Blocker Use During the Pandemic: The Pediatric Perspective.

Authors:  Andrew M South; Tammy M Brady; Joseph T Flynn
Journal:  Hypertension       Date:  2020-05-05       Impact factor: 10.190

7.  Angiotensin II inhibits satellite cell proliferation and prevents skeletal muscle regeneration.

Authors:  Tadashi Yoshida; Sarah Galvez; Sumit Tiwari; Bashir M Rezk; Laura Semprun-Prieto; Yusuke Higashi; Sergiy Sukhanov; Zipora Yablonka-Reuveni; Patrice Delafontaine
Journal:  J Biol Chem       Date:  2013-07-06       Impact factor: 5.157

8.  Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK.

Authors:  Jalahalli M Siddesha; Anthony J Valente; Siva S V P Sakamuri; Tadashi Yoshida; Jason D Gardner; Naveen Somanna; Chiaki Takahashi; Makoto Noda; Bysani Chandrasekar
Journal:  J Mol Cell Cardiol       Date:  2013-10-02       Impact factor: 5.000

Review 9.  ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis.

Authors:  A C Simões e Silva; K D Silveira; A J Ferreira; M M Teixeira
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

Review 10.  Renin-angiotensin system in the pathogenesis of liver fibrosis.

Authors:  Regina Maria Pereira; Robson Augusto Souza dos Santos; Filipi Leles da Costa Dias; Mauro Martins Teixeira; Ana Cristina Simões e Silva
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.